NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.68% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 2.62% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 2.58% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 2.16% |
| NVAX | Novavax Inc | Healthcare | Biotechnology | 2.12% |
| WVE | Wave Life Sciences Ltd | Healthcare | Biotechnology | 1.91% |
| GERN | Geron Corporation | Healthcare | Biotechnology | 1.84% |
| MORF | Morphic Holding Inc | Healthcare | Biotechnology | 1.74% |
| EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 1.53% |
| APLT | Applied Therapeutics Inc | Healthcare | Biotechnology | 1.48% |
| CNTA | Centessa Pharmaceuticals PLC ADR | Healthcare | Biotechnology | 1.48% |
| BLTE | Belite Bio Inc ADR | Healthcare | Biotechnology | 1.44% |
| ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.41% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.37% |
| VRDN | Viridian Therapeutics Inc | Healthcare | Biotechnology | 1.34% |
| IRON | Disc Medicine Inc. | Healthcare | Biotechnology | 1.33% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 1.28% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.24% |
| SAVA | Cassava Sciences Inc | Healthcare | Biotechnology | 1.23% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 1.23% |